Research Paper Volume 15, Issue 24 pp 14845—14863
A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer
Figure 7. Clinical characteristics of KIFC1 in pancreatic adenocarcinoma. Variation analysis of KIFC1 expression in different Ages (A), M stage (B), N stage (C), T stage (D), pathological stages (E), and histologic grade (F). (G, H) The prognostic significance of KIFC1 in pancreatic cancer was analyzed by univariate and multivariate Cox analysis. (I) Prognostic evaluation efficacy of KIFC1 in pancreatic cancer by ROC. (J) Calibration curve for evaluating the accuracy. (K) A nomogram based on KIFC1 expression and Pathological stage, Gender, Age, and Histologic grade. Ns: p ≥0.05; *p < 0.05; **p < 0.01; ***p < 0.001. ****p < 0.0001.